EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, IMDX: Insight Molecular Diagnostics Inc

07 Nov 25 14:28
LAST:

6.200

CHANGE:
 0.30		OPEN:
6.480		HIGH:
6.490		ASK:
0.000		VOLUME:
51.0K
CHG(%):
4.62		PREV:
6.500		LOW:
6.120		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 256.4806.4906.1206.20051.0K
06 Nov 256.7206.7206.1006.50064.4K
05 Nov 256.1506.7905.9706.66065.6K
04 Nov 256.1506.2005.8006.13038.7K
03 Nov 255.8206.2005.8006.12052.5K
31 Oct 255.8706.1455.7506.01035.6K
30 Oct 255.9106.1005.5405.92558.8K
29 Oct 256.1506.3105.5005.910104.8K
28 Oct 256.5506.5505.5506.220135.1K
27 Oct 256.6306.7006.4006.50069.6K

COMPANY PROFILE

Name:Insight Molecular Diagnostics Inc
About:Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers VitaGraft Kidney, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for kidney transplantation; VitaGraft Liver, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for liver transplantation; and GraftAssure, a dd-cfDNA test that uses droplet digital PCR technology to measure the concentration of dd-cfDNA using 48 predefined SNPs. In addition, it provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. for the development and commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. Insight Molecular Diagnostics Inc. was formerly known as OncoCyte Corporation and changed its name to Insight Molecular Diagnostics Inc. in June 2025. Insight Molecular Diagnostics Inc. was incorporated in 2009 and is based in Nashville, Tennessee.
Sector:Healthcare
Address:2 International Plaza Dr., Nashville, TN, United States, 37217
Website:https://imdxinc.com
FIGI:BBG008P5VFV1

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:6.342.2%
MA10:6.230.4%
MA20:5.826.5%
MA50:4.2246.8%
MA100:3.5375.8%
STO9:42.05
STO14:42.05
RSI14:56.48
WPR14:-50.67
MTM14:-0.35
ROC14:-0.05 
ATR:0.61 
Week High:6.799.5%
Week Low:5.757.8%
Month High:6.799.5%
Month Low:3.30

RECENT SPLITS

Date Ratio
25 Jul 20231-20